Tennessee hospital using AI-assisted device for polyp detection in clinical trial

Chattanooga, Tenn.-based Erlanger Health System began a clinical trial to test an artificial intelligence device used to increase polyp detection during colonoscopy, thechattanoogan.com reported Feb. 8.

Advertisement

The health system is using a device by Magentiq Eye that uses AI software during a screening colonoscopy to identify polyps. The device is designed to complement the polyp-identification efforts of the endoscopist.

The AI software was taught to detect abnormalities after being shown thousands of images with various stages of polyp development.

Arslan Kahloon, MD, chief of gastroenterology at Erlanger, said, “We think cancers that happen between colonoscopies are due to missed polyps hiding behind the folds or flat and difficult to find polyps, so if we can find these polyps with any kind of extra detection system then we can deal with them accordingly.”

The trial is currently recruiting patients.

More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.